Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., commonly referred to as Sinopep, is a leading player in the biopharmaceutical industry, headquartered in Jiangsu, China. Established in 2003, the company has made significant strides in the development and production of innovative biopharmaceutical products, focusing on areas such as peptide synthesis and drug formulation.
Sinopep's core offerings include a range of high-quality peptides and biologics, distinguished by their advanced manufacturing processes and commitment to research and development. The company has positioned itself as a trusted partner in the global pharmaceutical market, catering to both domestic and international clients.
With a strong emphasis on quality and innovation, Sinopep has achieved notable milestones, solidifying its reputation as a key contributor to the biopharmaceutical landscape. Its dedication to excellence continues to drive its growth and influence within the industry.
-19 vs industry average
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.’s score of 23 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the most carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. yet.
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., headquartered in China (CN), currently does not have available carbon emissions data for the most recent year. As a result, specific figures regarding their total emissions, including Scope 1, Scope 2, and Scope 3 emissions, are not provided.
The company has not outlined any reduction targets or climate commitments, indicating a lack of formal initiatives in this area at present. Furthermore, there are no emissions data cascaded from a parent or related organization, as the company operates independently in this regard.
In the context of the biopharmaceutical industry, it is essential for companies to establish clear climate commitments and reduction strategies to align with global sustainability goals. Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. may benefit from developing such initiatives to enhance their environmental performance and contribute to broader climate action efforts.
No climate goals have been disclosed for Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. yet.
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more